The Role of Circulating Tumor Cells as a Liquid Biopsy for Cancer: Advances, Biology, Technical Challenges, and Clinical Relevance
Cancer remains a leading cause of mortality worldwide, with metastasis significantly contributing to its lethality. The metastatic spread of tumor cells, primarily through the bloodstream, underscores the importance of circulating tumor cells (CTCs) in oncological research. As a critical component o...
Main Author: | Tyler A. Allen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-03-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/16/7/1377 |
Similar Items
-
Emerging Lab-on-a-Chip Approaches for Liquid Biopsy in Lung Cancer: Status in CTCs and ctDNA Research and Clinical Validation
by: Ângela Carvalho, et al.
Published: (2021-04-01) -
Liquid Biopsy in Lung Cancer: Biomarkers for the Management of Recurrence and Metastasis
by: Vanessa G. P. Souza, et al.
Published: (2023-05-01) -
Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
by: Qianwei Ye, et al.
Published: (2019-07-01) -
Dangerous Liaisons: Circulating Tumor Cells (CTCs) and Cancer-Associated Fibroblasts (CAFs)
by: Pablo Hurtado, et al.
Published: (2020-10-01) -
Liquid Biopsy in Melanoma: Significance in Diagnostics, Prediction and Treatment Monitoring
by: Paula Kamińska, et al.
Published: (2021-09-01)